NG-201

N/A

Report date: 2025/01/26 16:04:45

Base Information

Drug NameNG-201
Drug Alias NameAAV-VEGF gene therapy (Neuracle Genetics)NG-201
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor gene transference
TargetsVascular endothelial growth factor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuracle Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuracle Genetics Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A